Response to: Comment on "First-Line Helicobacter pylori Eradication with Vonoprazan, Clarithromycin, and Metronidazole in Patients Allergic to Penicillin"

Affiliations

¹ Department of Gastroenterology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
² Department of Gastroenterology, Institute for Adult Disease, Asahi Life Foundation, Tokyo, Japan.
³ Advanced Medical Research Center, Yokohama City University, Yokohama, Japan.

Comment

Soichiro Sue et al. Gastroenterol Res Pract. 2018.

. 2018 Mar 22:2018:8046838.

doi: 10.1155/2018/8046838. eCollection 2018.

¹ Department of Gastroenterology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
² Department of Gastroenterology, Institute for Adult Disease, Asahi Life Foundation, Tokyo, Japan.
³ Advanced Medical Research Center, Yokohama City University, Yokohama, Japan.

No abstract available

Comment on

Comment on "First-Line Helicobacter pylori Eradication with Vonoprazan, Clarithromycin, and Metronidazole in Patients Allergic to Penicillin".
Kashani N, Talebi Bezmin Abadi A. Kashani N, et al. Gastroenterol Res Pract. 2018 Feb 20;2018:5173904. doi: 10.1155/2018/5173904. eCollection 2018. Gastroenterol Res Pract. 2018. PMID: 29676395 Free PMC article. No abstract available.

1. Kashani N., Abadi A. T. B. Comment on “first-line Helicobacter pylori eradication with vonoprazan, clarithromycin, and metronidazole in patients allergic to penicillin”. Gastroenterology Research and Practice. 2018;2018:3. doi: 10.1155/2018/5173904.5173904 - DOI - PMC - PubMed
1. Sue S., Suzuki N., Shibata W., et al. First-line Helicobacter pylori eradication with vonoprazan, clarithromycin, and metronidazole in patients allergic to penicillin. Gastroenterology Research and Practice. 2017;2017:6. doi: 10.1155/2017/2019802.2019802 - DOI - PMC - PubMed
1. Sue S., Kuwashima H., Iwata Y., et al. The superiority of vonoprazan-based first-line triple therapy with clarithromycin: a prospective multi-center cohort study on Helicobacter pylori eradication. Internal Medicine. 2017;56(11):1277–1285. doi: 10.2169/internalmedicine.56.7833. - DOI - PMC - PubMed
1. Kawai T., Yamagishi T., Yagi K., et al. Tailored eradication therapy based on fecal Helicobacter pylori clarithromycin sensitivities. Journal of Gastroenterology and Hepatology. 2008;23(Supplement 2):S171–S174. doi: 10.1111/j.1440-1746.2008.05408.x. - DOI - PubMed
1. Ono S., Kato M., Nakagawa S., Mabe K., Sakamoto N. Vonoprazan improves the efficacy of Helicobacter pylori eradication therapy with a regimen consisting of clarithromycin and metronidazole in patients allergic to penicillin. Helicobacter. 2017;22(3) doi: 10.1111/hel.12374. - DOI - PubMed